DePuy Orthopaedics has acquired BioMedical Enterprises, a manufacturer of Nitinol orthopaedic implants for small bone fixation to treat bunions, hammertoes, hand/wrist deformities, etc.
Histogenics acquired development and commercialization rights to NeoCart® for the Japanese market from its partner, Purpose Co. NeoCart autologous cell therapy is designed to treat knee cartilage defects.Â
Study results suggest that Moximed’s Atlas™ knee provided rapid, clinically-effective pain relief for patients with early knee OA in the pre-arthroplasty disease stage.
Orthocell was granted ethical approval in Australia for a clinical study of a microfracture technique using the Celgro SMRT Graft collagen scaffold.
Bone Therapeutics completed recruitment for its ALLOB® allogeneic cell therapy Phase IIA spinal fusion study. The company will extend the trial to assess early onset of bone formation and fusion.
Since launch in 2009, SI-BONE’s iFuse Implant System® has been used in >20,000 procedures worldwide. The product was recently launched in Australia and New Zealand.
CoreLink commenced U.S. launch of Entasis™, reportedly the only sacroiliac joint fusion system that self-harvests bone graft while simultaneously compressing the joint.